Medrobotics Announces Appointment of Mark Peters As Chief Financial Officer and Treasurer

April, 23 2012 - Medrobotics Corporation is pleased to announce the appointment of Mark Peters to the position of Chief Financial Officer and Treasurer. Mr. Peters has over 20 years of financial leadership, operational management, and strategic planning experience with both private and publicly held companies, including successful IPO experience. Mr. Peters' has been in healthcare most of his career having been Chief Financial Officer and Vice President of Finance for companies including Associates of Cape Cod, a global manufacturer and supplier of endotoxin detection re-agents for the medical device and pharmaceutical industries, and two venture backed commercial companies, IST and Health Language. In addition, Mr. Peters had the operating role of General Manager for Aura Medsystems, an early stage medical device company which developed a novel wound closure technology licensed from Massachusetts General Hospital. His previous experience also includes progressive financial management positions with IBM and PriceWaterhouseCoopers. Mr. Peters is a licensed CPA and holds a BBA in Accounting from The University of Texas and an MBA in Finance from The University of Notre Dame.

Mr. Peters' appointment coincides with the Company's near term plans of commercializing its products in several countries in addition to North America.

About Medrobotics

Medrobotics Corporation ( is a privately held company headquartered in Raynham, Massachusetts, that is developing and commercializing the Flex™ System, a robotic assist platform that enables surgeons to gain single-site access and visualization to difficult-to-access anatomical locations. The system provides a precise and stable platform for enhanced visualization, and enables two-handed dexterity with compatible third-party tools having tactile feedback. The Flex™ System is anticipated to be commercially available in 2013.



Medrobotics' Flex® System Honored With One Of Top 100 Annual Best of What's New Awards, Nov. 21, 2014 More

Medrobotics Closes $20 Million Financing: Company Extends its Runway for Commercialization of the Ground-Breaking Flex® System in Otolaryngology, Oct. 20, 2014 More

Medrobotics Announces Launch of the Flex® Retractor, Sept. 18, 2014 More

Surgeons Complete Cancer Surgery with Medrobotics’ Flex® System in Front of a Live Audience at Head and Neck Surgical Course at University Hospital of Marburg, Sept. 1, 2014 More

Surgeons of the University Hospital Essen Complete World’s First Robotic-Assisted Cancer Surgery with Medrobotics' Flex® System, July 20, 2014 More

University Hospital Dinant Godinne-UCL Namur Completes World’s First Robotic-Assisted Surgery with Medrobotics‘ Flex® System, June 18, 2014 More

Medrobotics Closes $26 Million Series E Financing, May 13, 2014 More

Medrobotics Corporation Receives CE Mark for the Flex® System, Mar. 18, 2014 More

Medrobotics Appoints Russell M. Singleton, Ph.D., as Senior Vice-President R&D, Mar. 17, 2014 More

Medrobotics Appoints Thomas F. Patzelt Vice-President Marketing, Jan. 2, 2014 More

Medrobotics Gains ISO 13485: 2003 Certification for the Design, Manufacture, Service and Distribution of the Flex™ System, Nov. 3, 2013 More

Medrobotics Closes On $10 Million Financing From Hercules, March 22, 2013 More

Medrobotics Appoints Richard S. Walsh Vice-President Global Sales, Feb. 4, 2013 More

Medrobotics Completes $33.6 Million Series D Financing: Company Prepares for Commercialization of the Ground-Breaking Flex™ System in Otolaryngology, Dec. 20, 2012

Medrobotics Corporation. ©2014. All rights reserved.   Legal Information  •  Privacy Policy